Diffusion tensor metrics as biomarkers in Alzheimer's disease.
about
Diffusion tensor imaging in Alzheimer's disease: insights into the limbic-diencephalic network and methodological considerationsIn vivo quantitative susceptibility mapping (QSM) in Alzheimer's diseaseDiffusion tensor MRI as a biomarker in axonal and myelin damage.Brain connectivity in neurodegenerative diseases--from phenotype to proteinopathy.Alterations of diffusion tensor MRI parameters in the brains of patients with Parkinson's disease compared with normal brains: possible diagnostic use.Regional MRI Diffusion, White-Matter Hyperintensities, and Cognitive Function in Alzheimer's Disease and Vascular Dementia.Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.Group-Level Progressive Alterations in Brain Connectivity Patterns Revealed by Diffusion-Tensor Brain Networks across Severity Stages in Alzheimer's Disease.Effects of insulin resistance on white matter microstructure in middle-aged and older adults.From Phineas Gage and Monsieur Leborgne to H.M.: Revisiting Disconnection Syndromes.Corpus callosum shape and size changes in early Alzheimer's disease: a longitudinal MRI study using the OASIS brain databaseWhite matter disruption at the prodromal stage of Alzheimer's disease: relationships with hippocampal atrophy and episodic memory performance.Effects of the coexistence of late-life depression and mild cognitive impairment on white matter microstructureQuantitative multimodal multiparametric imaging in Alzheimer's disease.Imaging the accumulation and suppression of tau pathology using multiparametric MRI.Altered Superficial White Matter on Tractography MRI in Alzheimer's Disease.Effectiveness of regional DTI measures in distinguishing Alzheimer's disease, MCI, and normal agingExploring Patterns of Alteration in Alzheimer's Disease Brain Networks: A Combined Structural and Functional Connectomics AnalysisLeft hemisphere diffusivity of the arcuate fasciculus: influences of autism spectrum disorder and language impairment.White matter degeneration in subjective cognitive decline: a diffusion tensor imaging study.Presymptomatic and longitudinal neuroimaging in neurodegeneration--from snapshots to motion picture: a systematic review.Longitudinal white matter changes in frontotemporal dementia subtypes.Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study'.ApoE influences regional white-matter axonal density loss in Alzheimer's disease.Multimodal analysis of functional and structural disconnection in Alzheimer's disease using multiple kernel SVM.White Matter Degradation is Associated with Reduced Financial Capacity in Mild Cognitive Impairment and Alzheimer's Disease.Multimodal imaging brain connectivity analysis (MIBCA) toolbox: preliminary application to Alzheimer's disease.Cognitive and brain structural changes in a lung cancer population.White matter hyperintensity microstructure in amyloid dysmetabolism.Cardiorespiratory Fitness and White Matter Neuronal Fiber Integrity in Mild Cognitive Impairment.Central white matter degeneration in bulbar- and limb-onset amyotrophic lateral sclerosis.Olfactory identification deficit predicts white matter tract impairment in Alzheimer's disease.Short-term white matter alterations in Alzheimer's disease characterized by diffusion tensor imaging.Following the Spreading of Brain Structural Changes in Alzheimer's Disease: A Longitudinal, Multimodal MRI Study.Specific Patterns of White Matter Alterations Help Distinguishing Alzheimer's and Vascular Dementia.White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease
P2860
Q30588684-0F57D3BB-0108-4989-8C00-926541A20E04Q30701725-EE4A9886-2B34-4B90-B0D2-EF1BFB5E13FEQ30814256-D61D7A56-060E-4CB5-BCE7-4C69895732C8Q30857734-E09B4881-34E1-4DD1-9541-3E2D1E8DC2DDQ31053308-3023522C-013A-4077-ABC0-E32B50AFBCFAQ31076171-1C21D23F-6C6E-4F50-9A75-CCE7D31F8366Q31153910-9A2AE600-0AE8-458A-9737-43C172439BBAQ33881832-9DB1A1FB-A664-4B64-ACD1-C297849D34D0Q33927185-35D54373-2966-4FD9-B212-8343AF9FBBEBQ34489461-833B4EA1-D6FB-4F03-817A-B9E0F754305FQ35041909-6E8DF4A5-A89C-4A2C-B3C9-B1CC247D508EQ35079120-94710699-EB36-4B9E-A56C-9CC3357CF3DDQ35596915-8C2D6577-DE73-4CBA-AEE2-E53696EA5B45Q36164757-45904526-BA6F-4F4A-B3D2-78571611FA9DQ36663462-1753A313-7ED4-4059-BDFA-9470B4DE5A2FQ37122836-95C2D2B0-066F-4B73-9AE8-17A22188E5BBQ37220884-F6F3AAB5-CD2D-479D-B10E-673103BD9976Q37235658-A8FA757D-7A5C-4AF9-9928-A0F4183D83EEQ37673445-7BB9000F-9E47-4FC0-9D33-267E69F46573Q37688073-4F37138D-054C-4BCA-8288-456E7324E368Q38336261-175A0BE8-9D3C-426B-A4B6-704ABC13BA2EQ38426470-74E4D0F5-E6EF-4406-B6A1-3A88DA0B5887Q40873275-B8F87C80-A74F-4DC6-A118-555DB396806CQ41198390-D72C8A6A-BBF9-49BF-9FC8-4C3D07123DDBQ41460468-79B1AC4C-67C4-4D57-B036-90BCA94A4500Q42251851-3C80867D-35F3-4E7D-B2E2-04BA201E981AQ42577736-D657266E-EDF0-4879-822D-CD5FB82B3C31Q42627081-1F84BC46-85DD-4BE7-AE1C-9EAE6F41492CQ47147506-DA00E4CF-D64A-4487-B1E3-10315156F452Q47332392-108ABFE2-2B66-484F-86B6-0B7850F75294Q48639135-FA7C2033-67B1-4984-BE4E-FCC75FE7C483Q50577989-3B162F0B-DC1E-437B-8516-F48DEE476CDEQ50873893-2CBFB627-E06A-4BB9-900E-A946884BA937Q52148901-45F90FBB-161E-4C27-82A5-8445051D93C7Q55330837-57BC0BD8-2BCD-4574-B2A7-EC2D5EF01BA9Q58698141-11A66EDB-639A-4F52-8F6A-DD62D61716AC
P2860
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
description
2012 nî lūn-bûn
@nan
2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@ast
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@en
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@nl
type
label
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@ast
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@en
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@nl
prefLabel
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@ast
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@en
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@nl
P2093
P2860
P1433
P1476
Diffusion tensor metrics as biomarkers in Alzheimer's disease.
@en
P2093
George Pengas
Guy B Williams
Stephanie Alley
P2860
P304
P356
10.1371/JOURNAL.PONE.0049072
P407
P577
2012-11-07T00:00:00Z